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Keratinocytes respond to injury by releasing the
proin¯ammatory cytokine interleukin-1, which
serves as the initial ``alarm signal'' to surrounding
cells. Among the consequences of interleukin-1
release is the production of additional cytokines and
their receptors by keratinocytes and other cells in the
skin. Here we describe an additional effect of inter-
leukin-1 on keratinocytes, namely the alteration in
the keratinocyte cytoskeleton in the form of the
induction of keratin 6 expression. Keratin 6 is a mar-
ker of hyperproliferative, activated keratinocytes,
found in wound healing, psoriasis, and other in¯am-
matory disorders. Skin biopsies in organ culture
treated with interleukin-1 express keratin 6 in all
suprabasal layers of the epidermis, throughout the
tissue. In cultured epidermal keratinocytes, the
induction of keratin 6 is time and concentration
dependent. Importantly, only con¯uent keratinocytes
respond to interleukin-1, subcon¯uent cultures do
not. In the cells starved of growth factors, epidermal
growth factor or tumor necrosis factor-a, if added
simultaneously with interleukin-1, they synergisti-
cally augment the effects of interleukin-1. Using
DNA-mediated cell transfection, we analyzed the
molecular mechanisms regulating the keratin 6
induction by interleukin-1, and found that the induc-
tion occurs at the transcriptional level. We used a
series of deletions and point mutations to identify
the interleukin-1 responsive DNA element in the
keratin 6 promoter, and determined that it contains
a complex of C/EBP binding sites. The transcription
factor C/EBPb binds this element in vitro, and the
binding is augmented by pretreatment of the cells
with interleukin-1. The interleukin-1 responsive ele-
ment is clearly distinct from the epidermal growth
factor responsive one, which means that the proin-
¯ammatory and proliferative signals independently
regulate the expression of keratin 6. Thus, interleu-
kin-1 initiates keratinocyte activation not only by
triggering additional signaling events, but also by
inducing directly the synthesis of keratin 6 in epider-
mal keratinocytes, and thus changing the composi-
tion of their cytoskeleton. Key words: C/EBPb/
in¯ammation/nuclear factor NFkB/organ culture/transcrip-
tional regulation. J Invest Dermatol 116:330±338, 2001
T
he epidermis, a multilayered tissue made of and by
keratinocytes, provides our ®rst line of defense from
external insults. It has been appreciated for a long
time that epidermis passively protects the host from
desiccation, chemical damage, and physical damage,
such as mechanical injury or ultraviolet light. More recently,
protection through active immunologic events was demonstrated,
when it was realized that keratinocytes, when damaged, actively
initiate in¯ammatory processes by releasing a system of signals
consisting of cytokines and growth factors (Barker et al, 1991;
Ollier, 1992).
The most likely candidate for a signal that initiates such
in¯ammation is the cytokine interleukin (IL)-1 (Groves et al,
1996). IL-1, in both the IL-1a and the IL-1b form, is present in
healthy epidermis, but because it is cytoplasmic, IL-1 is unavailable
to its receptor. When keratinocytes are damaged, however, the pre-
stored IL-1 is released and it serves as a paracrine signal to ®broblasts
to produce prostaglandins and collagenase, to endothelial cells to
express selectins, as well as to lymphocytes, leading to their
chemotaxis toward the site of injury (Dinarello and Wolff, 1993).
In addition, IL-1 serves as the autocrine signal to the surrounding
undamaged keratinocytes, stimulating them to become activated
(Kupper, 1990). Activated keratinocytes are migratory and
hyperproliferative, producing a cornucopia of growth factors and
cytokines that function in the in¯ammatory and wound healing
processes. Among the products of keratinocytes activated by IL-1
are IL-3, IL-6, IL-8, granulocyte-macrophage colony-stimulating
factor, tumor necrosis factor (TNF)-a, and transforming growth
factor-a. The production of IL-1 is further augmented by IL-1,
TNF-a, and transforming growth factor-a, which can, in a series
of interconnected autocrine loops, ``conspire'' to keep keratino-
cytes in an activated state (Kupper and Groves, 1995).
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The IL-1 signal originates at the cell surface receptor, IL-1R type
I, which avidly binds IL-1a, IL-1b, and IL-1ra, a receptor
antagonist. A soluble form of the receptor, sIL-1R, competes for
IL-1, attenuating the signal. Another high-af®nity receptor, IL-1R
type II, apparently does not transduce a signal and may actually be a
``decoy'' receptor, also attenuating the effects of IL-1 (Sims et al,
1993). Apparently, keratinocytes have developed elaborate strate-
gies both to respond to and to protect themselves from IL-1
(Mizutani et al, 1991; Kupper and Groves, 1995).
Among the molecular effects of IL-1 is activation of signal
transducing kinases that activate transcription factors AP1 and
nuclear factor (NF) kB (Brasier et al, 1990; Novak et al, 1990; Lee
et al, 1994; Cao et al, 1996). IL-1 can activate at least four other
transcription factors: C/EBPb (also known as NF-IL-6 and LAP),
Myc, Myb, and Egr1 (Krox-24, Tis8, NGFI-A or zif-268).
Commonly, these factors cooperate in regulating gene expression
(Matsusaka et al, 1993; Stein and Baldwin, 1993; Klampfer et al,
1994; Sells et al, 1995). In various cell types this ¯urry of
transcriptional activation results in the induction of expression of
several proteins, such as collagenase, stromelysin, angiotensinogen,
and transcription factors Fos and Jun, in addition to the growth
factors and cytokines mentioned above.
IL-1 causes keratinocyte activation in epidermis. Among the
markers of activated keratinocytes is keratin K6 (Tomic-Canic et al,
1998). Keratins constitute a large family of cytoskeletal proteins,
differentially expressed in various epithelial cells (Schweizer, 1993).
They belong to two families, acidic and basic, are usually expressed
in pairs and the keratin ®laments are obligate heteropolymers of at
least one member from each family. The basal layer of the
epidermis produces keratins K5 and K14, whereas in the
differentiating, suprabasal layers K1, K2e, and K10 are produced.
Healthy interfollicular epidermis does not contain K6; however, it
is found in the outer root sheath of the hair follicle, the nail bed,
oral epithelia, and some other tissues. In epidermal wound healing,
psoriasis, carcinomas, and other pathologic states, keratin K6 is
expressed together with K16 or K17. Mutations in K6 keratin gene
cause pachyonychia congenita (Bowden et al, 1995). Our previous
results have shown that extracellular signals that cause keratinocyte
proliferation, speci®cally epidermal growth factor (EGF) and
transforming growth factor-a, can induce the expression of K6
and have characterized the transcription factors that bind its
promoter (Bernerd et al, 1993; Jiang et al, 1993).
Because IL-1 is an important initiator of keratinocyte activation,
we decided to determine whether IL-1 directly affects keratin gene
expression. If so, that would mean that IL-1 not only induces the
downstream signaling events, but also directly causes cytoskeletal
changes characteristic of activated keratinocytes. We found that
addition of IL-1 to organ culture of skin biopsies speci®cally
induces the expression of K6. A large collection of DNA constructs
containing keratin gene promoters was used to transfect cultures of
human epidermal keratinocytes. Addition of IL-1 to the medium
speci®cally increased the activity of the K6 promoter. Other keratin
gene promoters tested were not affected. Focusing on the K6
promoter sequence, we have identi®ed the DNA segment that
responds to the IL-1 signal. The segment contains several C/EBP
consensus sites and binds puri®ed C/EBPb protein in vitro. These
results show that IL-1, an initiator of keratinocyte activation,
directly induces the expression of keratin K6 in epidermis and
thereby causes changes in the keratinocyte cytoskeleton. Addition-
ally, our results begin to characterize the molecular signal
transduction pathways along which IL-1 regulates gene expression
in epidermis.
MATERIALS AND METHODS
DNA constructs and gel retardation experiments The plasmids
containing keratin promoters, the segments of the K6 promoter and the
control plasmids pRSVZ have been described previously (Jiang et al, 1993,
1994; Ma et al, 1997). The plasmid containing the IL-8 promoter was a gift
from J. Vilcek (NYU School of Medicine, New York, NY), the one
expressing the EGF receptor (EGFR) gene from J. Schlessinger (NYU
School of Medicine, New York, NY), and the one expressing C/EBPb
from S. Cheng (Cornell University). To clone the responsive element into
a heterologous vector, we ampli®ed the DNA using polymerase chain
reaction (PCR). The synthesized DNA contained the C/EBP sites
bracketed by restriction sites that facilitate cloning and were inserted into
the enhancer trap TK-CAT vector (Promega, Madison, WI), using its
BamHI cloning site. The CAT activity of the resulting plasmid was
compared with that of the parental control plasmid, TK-CAT. The Kaplan
Comprehensive Cancer Center Core Facility con®rmed the sequences of
the DNA inserted into the pGCAT vector using the dideoxy plasmid
sequencing method. All DNA used in transfections were puri®ed using the
Magic Megapreps DNA puri®cation system (Promega).
Cells and transfection HeLa cells were maintained in Dulbecco's
minimal essential medium supplemented with 10% bovine serum, and
transfected using modi®ed calcium phosphate precipitation procedure
(Jiang et al, 1991). Each transfection contained either 10 mg of K6 CAT per
dish, or 15 mg of K6 deletions and mutants per dish, together with 3 mg of
RSVZ construct per dish. The cells were then incubated with or without
IL-1a in combination with various inhibitors as indicated. In all
experiments we used the IL-1a form, except where speci®cally
indicated. The sources of cytokines and inhibitors were Immunex
(Seattle, WA) for IL-1a, IL-1 neutralizing antibody and antibodies
reacting with the IL-1 receptor; Sigma (St Louis, MO) for cyclic
adenosine monophosphate, forskolin, insulin, diacylglycerol, and
bisindolylmaleimide; Intergen (Purchase, NY) for TNF-a; U.B.I. (Lake
Placid, NY) for interferon-g and IL-1b; R&D Systems (Minneapolis, MN)
for EGF and phospholipase A. Eighteen to 48 hours after transfection cells
were washed twice with phosphate-buffered saline and harvested by
scraping. The cell disruption by repeated freeze-thaw cycles, as well as
CAT and b-galactosidase assays have also been described (Jiang et al, 1991).
In addition to using the functional assay, we measured the CAT protein
using a CAT enzyme-linked immunosorbent assay kit purchased from
Boehringer-Mannheim (Indianapolis, IN). Brie¯y, 96-well plates precoated
with anti-CAT antibody were incubated 1 h with samples and standards,
washed ®ve times, incubated with anti-CAT conjugate for 1 h, washed ®ve
times again, incubated again with anti-digoxigenin conjugated with
peroxidase and developed with chromogenic substrate with digoxigenin
for 30 min. The optical density of each well was measured with a
spectrophotometer using a 405 nm ®lter. These experiments were
performed using duplicate plates with a 490 nm ®lter for reference. All
CAT values were normalized for transfection ef®ciency by calculating the
ratio of CAT activity to b-galactosidase in each transfected plate. Each
transfection experiment was separately performed three or more times,
with each data point resulting from duplicate or triplicate transfections.
Normal human foreskin epidermal keratinocytes were ®rst cultured
using 3T3 feeder layers and then frozen in Liquid N2, as described (Simon
and Green, 1984; Randolph and Simon, 1994). Once thawed, the
keratinocytes were grown without feeder cells in KGM, a de®ned serum-
free keratinocyte medium supplemented with insulin, epidermal growth
factor and bovine pituitary extract (keratinocyte-SFM, GIBCO, San
Diego, CA). Cells were expanded through two 1:4 passages before
transfection and usually transfected 1 d after they reached 100% con¯uence.
Some 16±24 h before transfection, the cells were transferred into
keratinocyte basal medium (KBM). KBM is the same de®ned medium,
but without the bovine pituitary extract, EGF, insulin, hydrocortisone, or
thyroid hormone. Transfections using polybrene with dimethyl sulfoxide
shock were performed as previously described (Jiang et al, 1991).
Electrophoretic mobility shift assay Keratinocytes were grown to
con¯uence in KGM, the medium was switched to KBM for 16 h and then
the cells were either left untreated or treated with 50 ng per ml of IL-1.
After 40 min, cells from two 100 mm dishes were harvested by scraping,
collected by centrifugation, washed with phosphate-buffered saline and
resuspended in 100 ml of buffer containing 20 mM HEPES (pH 7.8), 450 mM
NaCl, 0.4 mM ethylenediamine tetraacetic acid, 0.5 mM dithiothreitol, 25%
glycerol and 0.5 mM phenylmethylsulfonyl ¯uoride. The cells were broken
by freeze-thawing in liquid N2 three times and centrifuged at 4°C to remove
debris. The protein concentration was determined and the extracts aliquoted
and stored at ±70°C until use. The extracts were thawed only once, on ice,
immediately prior to use. The probe was labeled using the Klenow fragment
(Boehringer-Mannheim) and [a32P]deoxycytidine triphosphate, 50 mCi
(Amersham, Piscataway, NJ) per reaction, and puri®ed by gel ®ltration
using Sephadex G50 columns (Chroma-Spin, Clontech, Palo Alto, CA). The
probes were annealed double-stranded DNA NFkB consensus GCC-
TGGGAAAGTCCCCTCAACT and K6 promoter ATTTTGCCCTGC-
CTAAAGGAAGCGAAAAATGCAATCTCGGTATTTCATAACTTT-
VOL. 116, NO. 2 FEBRUARY 2001 IL-1 REGULATES K6 KERATIN 331
TGTAATAATGC. Approximately 5 mg of the extract was initially incubated
for 15 min on ice with or without excess of unlabeled competitor, in the
presence of 1.5 mg of dIdC, a nonspeci®c competitor (Stratagene, La Jolla,
CA), in a ®nal volume of 25 ml. The binding buffer contained 20 mM Tris±
HCl pH 7.6, 5 mM MgCl2, 100 mM NaCl, 10% glycerol, 1 mM
dithiothreitol, 2% polyvinyl alcohol, and 0.1 mM ethylenediamine
tetraacetic acid. 32P-labeled oligonucleotide probe (30,000 cpm) was added
and the incubation continued for an additional 30 min on ice. The free and the
protein-bound DNA were separated on 5% polyacrylamide gels (acrylamide/
bisacrylamide = 29 : 1). The gels were prerun for 30 min in 1 3 Tris-borate
pH 7, EDTA 1 mM (TBE) buffer and then run for 2±2.5 h at 125 V. The gels
were transferred on to ®lter paper, dried and exposed to X-ray ®lm (X-omat,
Kodak, Rochester, NY) at ± 70 °C for 24±48 h with screen intensi®ers.
To obtain puri®ed C/EBPb protein we used the plasmid expressing
GST-tagged C/EBPb (Hsu and Chen-Kiang, 1993) to transform
BL21(DE3) Escherichia coli (US Biologicals, Swampscott, MA). The bacteria
were grown in Luria broth (LB) with Ampicilin to an OD600 of 0.8 and
induced with 1 mM isopropyl thiogalactose for 3 h. Subsequently, we used
the GST-bulk puri®cation kit that includes glutathione-Sepharose-4B and
followed the procedures recommended by the manufacturer (Pharmacia,
Uppsala, Sweden). We prepared un-tagged protein using thrombin to
remove the GST tag, but found the tagged and the native proteins to have
indistinguishable properties in gel shift assays. The yield and purity of the
proteins were assessed using standard sodium dodecyl sulfate polyacryla-
mide gels. The protein was incubated with the labeled probe, and the gels
were run, dried, and exposed as described above.
Immunohistochemical staining of normal human skin Pieces of
normal human skin were obtained immediately after surgery. They were
cut into pieces approximately 5 mm3, and incubated in KBM with or
without IL-1a (50 ng per ml, Intergen), in a humidi®ed incubator at 37°C
for 24 h. The biopsies were mounted in tissue Tec OCT compound
(Sakura Finetek, Torrance, CA) and immediately frozen in liquid nitrogen.
Sections, 4±6 mm thick, were obtained with a cryostat (Miles Laboratories,
Tarrytown, NY), ®xed with methanol/acetone for 10 min and incubated
with anti-keratin K6 antibody (Progen Biotechnik GMBH, Heidelberg,
Germany) as a primary antibody at 4°C overnight. The sections were
washed with phosphate-buffered saline three times and treated with
peroxidase-conjugated anti-mouse IgG secondary antibody (Vecstatin
ABC-mouse IgG kit from Vector Laboratories, Burlingame, CA), at
room temperature for 1 h. The samples were washed again with phosphate-
buffered saline, and incubated with ABC complex (Vector Laboratories) at
room temperature for 1 h and treated with 3,3¢-diaminobenzidine-
tetrahydrochloride (Dojindo, Kumamoto, Japan) and 0.01% H2O2 as a
substrate in Tris pH 7.6 for 2 min. The samples were observed and
photographed under a light microscope (Microphot-FXA, Nikon,
Melville, NY).
Reverse transcription±PCR from explant tissue Explanted skin
samples were incubated with or without IL-1 for 16 h, harvested, and total
RNA were isolated utilizing RNeasy RNA extraction kit from Qiagen
(Santa Clarita, CA). Either 5 or 50 mg of RNA were subjected to reverse
transcription±PCR, with the Access reverse transcription±PCR system
from Promega. We used commercial primers for G3PDH (Clontech), and
the K6 keratin primers are as follows: K6 reverse transcription±PCR
Reverse TGACTTGTCCAACGCCTTCG; K6 reverse transcription±
PCR Forward GAGATCGACCACGTCAAGAAGC. The PCR products
were subjected to agarose gel electrophoresis, visualized with ethidium
bromide (Sigma) with a transilluminator from UVP (Upland, CA) and
photographed with a photographing unit from Polaroid (Germany). The
densities of bands were quanti®ed utilizing an image scanner (GT-9000
from Epson, Tokyo, Japan).
RESULTS
IL-1 induces expression of keratin K6 protein in normal
human skin Keratinocytes grown in vitro produce copious
amounts of K6 protein and mRNA. It was, therefore, dif®cult to
demonstrate an increase in K6 protein levels in response to IL-1
(not shown). On the other hand, healthy interfollicular epidermis
does not contain K6, and therefore the induction of K6 expression
by IL-1 could be easily observed in organ culture (Fig 1). To
demonstrate the induction of K6 by IL-1 in epidermal
keratinocytes, we took advantage of a new ``nearly in vivo''
experimental system that uses organ culture of human skin samples
that would be otherwise discarded during surgery (Mutasim et al,
1993; Dickinson et al, 1994; Bhora et al, 1995; Stoll et al, 1997). We
obtained 3±5 mm diameter biopsies of human skin and placed them
in KBM culture medium. IL-1 was added to the experimental
samples, whereas the control samples were incubated without IL-1.
After 24 h the biopsies were removed from the medium, frozen,
sectioned, and the presence of K6 determined using speci®c
antibodies. IL-1 induced the expression of high amounts of K6
keratin within the 24 h period (Fig 1). As a control we used
antibody detecting keratin K17, this protein was not induced by IL-
1 (data not shown). Without IL-1 the presence of keratin K6 was
detected in the perifollicular and eccrine epithelia, where K6 is
normally seen. The K6 staining was present in all suprabasal
epidermal layers. The staining was intense throughout the treated
samples, suggesting that IL-1 entered the explants from the top,
through the stratum corneum.
We note, however, that at the edges of the biopsies after 24 h a
weak presence of K6 can be detected even in the absence of added
Figure 1. IL-1 induces the expression of K6
keratin protein in human skin biopsies. Small,
3 mm punch biopsies were placed in KBM con-
taining IL-1, actinomycin, or IL-1 neutralizing
antibody. The biopsies were frozen, sectioned,
and stained with an antibody recognizing K6 kera-
tin.
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IL-1. This induction of K6 is presumably due to the release of the
endogenous IL-1 by the peripheral keratinocytes damaged during
the surgical procedure, and can be prevented with antibodies
neutralizing IL-1 (Fig 1).
To determine whether the induction of K6 occurs at the mRNA
level, we used quantitative reverse transcription±PCR on IL-1-
treated and IL-1-untreated samples. As the internal control we used
GAPDH mRNA. As shown in Fig 2, the GAPDH mRNA levels
did not change in response to the IL-1 treatment; in contrast, we
saw a robust induction of the K6 mRNA in the IL-1-treated
samples. Because the regulation of keratin gene expression occurs
primarily at the level of transcription (Lu et al, 1994; Stellmach et al,
1991; Magnaldo et al, 1993; Ma et al, 1997; Maytin and Habener,
1998), these results suggest that the induction of K6 keratin protein
by IL-1 may also occur at the level of transcription initiation.
IL-1 induces transcription from the K6 keratin gene
promoter To determine whether IL-1 induces K6 keratin
gene transcription, we transfected HeLa cells with a panel of
DNA constructs containing human keratin gene promoters. As a
positive control we used the promoter of the human IL-8 gene,
shown previously to be strongly induced by IL-1 (Sica et al, 1990;
Komine et al, 1993). Indeed, we found the IL-1 induces the IL-8
promoter and, of all the human keratin genes tested, only the
promoter of the K6 gene (Fig 3A). The K6 promoter activity was
induced approximately 3-fold, whereas the IL-8 promoter activity
was induced 5-fold.
We were intrigued by this speci®city of induction, because of all
the promoters tested K6 is the only one found speci®cally in the
activated keratinocytes, which suggests a direct causal correlation
between IL-1 signaling and K6 expression during keratinocyte
activation. When we repeated these experiments, however, with
cultures of subcon¯uent, exponentially growing keratinocyte, we
found that neither IL-8 nor K6 promoters appeared induced.
Eventually, we found two reasons for this: ®rst, harsh transfection
procedures release copious amounts of IL-1 from keratinocytes into
the medium, thus increasing the background (Komine et al, 1994),
and second, exponentially growing keratinocytes attenuate their
responses to IL-1 (see below).
Consequently, when we transfected con¯uent cultures of
keratinocytes, we found a robust response of the IL-8 promoter
and unambiguously activation of the K6 promoter as well (Fig 3B).
We noted that in keratinocytes, as in HeLa cells, IL-1 reproducibly
and consistently induced only the K6 promoter. The effect of IL-1
is concentration dependent; in both cell types a broad peak, highest
at 15±50 ng per ml was observed (data not shown). The two
promoters, IL-8 and K6, show parallel induction, which suggests
that a similar mechanism regulates both.
Subcon¯uent keratinocytes do not respond to IL-1, but as they
reach con¯uence, they become responsive (Fig 4). The response is
highest 1 d after con¯uence, i.e., 1 d after no free surface can be
seen on the tissue culture dishes. On subsequent days, the IL-1
effects diminish somewhat. Again, IL-8 and K6 promoters respond
in parallel.
The responsiveness to IL-1 did not correlate with the amounts of
the two receptors produced by the cells, because using western
blots we found similar amounts of both type I and type II receptors
in con¯uent and con¯uent cultures (data not shown). Both
isoforms of IL-1, IL-1a, and IL-1b induced the expression of K6
(Fig 5A). To con®rm the speci®city of induction, we repeated the
transfection on the presence of IL-1 neutralizing antibody, which
blocked the effects of IL-1. As a control, we used TNF-a, also an
inducer of K6 (Komine et al, 2000). The IL-1 neutralizing
antibodies did not affect the induction of K6 by TNF-a (Fig 5B).
The induction of K6 keratin may be a component of complex
cytoskeletal changes in keratinocytes treated with IL-1. Indeed,
subtle phenotypic transformations are observed: cells treated for
24 h with IL-1 are ¯atter, swirled, less tightly packed, and whereas
their nuclei are more prominent, the cell±cell boundaries are less
distinct (Fig 6). Neutralizing antibodies abolished these effects of
Figure 2. IL-1 induces the expression of K6 keratin mRNA in
human skin biopsies. Total RNA from explants of skin samples was
extracted, and 5 or 50 mg of RNA was ampli®ed in reverse transcription±-
PCR with keratin K6 primers and G3PDH primers as the control.
Incubation with IL-1 signi®cantly induced in vivo keratin K6 mRNA levels
compared with untreated samples, whereas the GAPDH mRNA levels did
not change.
Figure 3. IL-1 induces the expression of the K6 keratin gene
promoter. (A) Constructs containing keratin gene promoters linked to
CAT reporter gene were transfected into HeLa cells. These were then
grown in the presence or absence of IL-1, harvested after 48 h and the levels
of CAT activity in extracts determined. Because each promoter tested has
different intrinsic activity, the activities in the absence of IL-1 were taken as
1. As a positive control the promoter of the human IL-8 gene was used.
Each transfection was performed in duplicate plates, three to six times in
this and all subsequent experiments. Error bars represent differences
between duplicate plates. (B) The same constructs were transfected into
con¯uent cultures of human epidermal keratinocytes. Although the
method of transfection was different, as were the culture conditions, the
results were equivalent to those in HeLa cells. The induction of K6 by IL-1
in keratinocytes is consistent and ranges from 2.2- to 4.0-fold, depending
on the source of keratinocytes, length of time at con¯uency, culture
medium, etc.
Figure 4. Only con¯uent cultures of keratinocytes respond to IL-1.
Cultures were seeded on the same day and then transfected with the IL-8 or
the K6 promoter (left panels) at consecutive days. The cells are most
responsive 1 d after they reach con¯uence. The error bars represent the
differences between duplicate samples in a representative of three or more
transfection experiments.
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IL-1. TNF-a produced cytoskeletal changes similar to those
produced by IL-1, these were unaffected by the antibody (Fig 6).
The effects of the culture medium on K6 induction by IL-
1 The effect of IL-1 on K6 promoter depends on the medium
used to culture the cells. We observed the effects only if we
transferred the keratinocytes from KGM into KBM for 16 h before
transfection (Fig 7A). Shorter times, 0 or 2 h, did not make possible
the IL-1 effects. KGM differs from KBM because it contains
growth factors, such as insulin, EGF, and bovine pituitary extract.
We hypothesized that some of the ingredients in the KGM might
inhibit the induction by IL-1. Indeed, the addition of EGF to KBM
blocked the effect of IL-1, whereas the removal of EGF from the
KGM allowed it (Fig 7B). We conclude that EGF speci®cally
blocks regulation of K6 by IL-1. At present the molecular
mechanisms responsible for this effect are unknown, but among
the possible explanations are that EGF in the medium attenuates the
responsiveness of keratinocytes to IL-1 by blocking the signal
transduction pathway from the IL-1 receptor to the nucleus.
Alternatively, EGF by itself may fully activate the K6 promoter so
that further activation by IL-1 is impossible (Jiang et al, 1993).
IL-1 has been reported to induce phosphorylation of EGFR, and
thereby modulation of its activity (Bird and Saklatvala, 1989). This
raises the formal possibility that IL-1 acts through activation of the
EGF signaling pathway, which would explain the blocking of the
IL-1 effect in the presence of EGF; however, this is not the case in
regulation of K6. The regulation by EGF depends on the EGFR,
and when we cotransfected K6 with a construct overexpressing
EGFR, we found that the induction by EGF was greatly
augmented (Fig 7C); however, overexpressing EGFR had minimal
in¯uence on the regulation by IL-1, which means that the signaling
by IL-1 does not depend on EGFR.
We also examined the interactions between IL-1 on one hand
and insulin or interferon-g on the other. Insulin as a component of
KGM could inhibit the IL-1 effect, similar to EGF; however, we
found that insulin had no effect on the regulation by IL-1 (Fig 8).
Interferon-g is commonly found in cutaneous in¯ammatory
processes and can induce the expression of IL-1R in keratinocytes
(Kupper, 1990). Because IL-1 and interferon-g are often found
together in skin in vivo, we examined the interactions between the
two cytokines in keratinocytes. Whereas the EGF signaling affects
the IL-1 signaling in a complex way (Fig 7), the interferon-g
signaling and the IL-1 signaling do not interact (Fig 8). The IL-8
promoter activity can be induced by either cytokine, and when
together they have a simple additive effect. Interferon-g, however,
has no effect on K6 expression, either added alone or together with
IL-1, which means that the interferon-g and IL-1 signaling
pathways are independent (Jiang et al, 1994; Komine et al, 1996).
Mapping the IL-1 responsive DNA element Several
transcription factors respond to IL-1 and transduce its signal to
the nucleus, including NFkB, C/EBPb, and AP1. We prepared cell
extracts from IL-1 treated and control keratinocytes and used these
in gel shift studies with the consensus NFkB and AP1 elements and
the segment of the K6 promoter containing a cluster of C/EBP sites
as target DNA. The addition of IL-1 activates NFkB and C/EBP
binding (Fig 9). In contrast, the AP1 binding activity, already
relatively high in these cells, was not further activated by IL-1 (data
not shown).
In the promoter of the K6 gene we found one NFkB site, two
AP1 sites, and several C/EBP sites (Fig 10). To determine whether
Figure 6. Cytoskeletal changes in keratinocyte
cultures treated with IL-1 or TNF-a. Cells
were either left untreated, as control (top left), or
treated for 24 h with IL-1 or TNF-a. The treated
cells are ¯atter, swirled, less tightly packed, and
whereas their nuclei are more prominent, the
cell±cell boundaries are less distinct. The IL-1
neutralizing antibody reverses the phenotypic
changes caused by IL-1, but not by TNF-a.
Figure 5. Speci®city of induction of K6 by IL-1. (A) IL-1a and IL-1b
have similar effects on the K6 keratin gene promoter (top right). (B) An IL-1
neutralizing antibody abolishes the induction of K6 by IL-1. As a control
we used TNF-a, the effects of which are not inhibited by the antibody.
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any of these sites constitutes the IL-1 response element, we
prepared a series of K6 promoter deletion constructs leaving
progressively shorter DNA sequences. These constructs were tested
by transfection into HeLa cells and keratinocytes. The constructs
that remove the NFkB site and one or both AP1 sites were fully
responsive to IL-1 (Fig 10), which means that the NFkB and AP1
sites do not play a part in the induction of K6 by IL-1. Whereas the
deletion D180 is fully responsive to IL-1, the deletion D172, which
removes another 8 base pairs and importantly a part of the cluster of
C/EBP sites, showed a reduced IL-1 responsiveness. The deletion
D139, which removes all C/EBP sites, was not responsive. This
suggests that the cluster of C/EBP sites is essential for IL-1
signaling. All these constructs were fully responsive to EGF, which
means that in the K6 promoter the IL-1 and the EGF responsive
sites are separate and independent (Fig 10).
To establish whether the identi®ed IL-1 responsive element is
suf®cient for IL-1 responsiveness, we cloned it into a context of the
thymidine kinase gene. Two constructs were prepared, the shorter,
ES, contained 60 base pairs, and the longer, EL, 121 (Fig 11A).
Whereas the recipient vector, TK-CAT, was not responsive to IL-
1, both ES and EL were (Fig 11A). Note that the responsiveness to
EGF has not been transferred with the K6 sequences, neither ES
nor EL is responsive to EGF. The C/EBP family contains several
members and these are expressed in keratinocytes (Brasier et al,
1990; Maytin and Habener, 1998), although C/EBPb is the family
member shown to be speci®cally activated by IL-1 (Akira et al,
1991). To determine whether the identi®ed sequence in K6
promoter binds C/EBPb, we performed electrophoretic mobility
shift assays using bacterially expressed, puri®ed C/EBPb protein
and a synthetic DNA oligonucleotide that contains the IL-1
responsive element (Fig 11B). Indeed we found that C/EBPb
binds this sequence. Furthermore, when we cotransfected a vector
expressing C/EBPb with K6CAT, we found that C/EBPb greatly
augmented the activity of the K6 promoter. Additional cotransfec-
tion of a vector expressing CHOP (GADD153), a speci®c
antagonist of C/EBPb (Ron and Habener, 1992), blocked both
the IL-1-induced and the C/EBPb-induced activation of K6CAT.
We conclude from these data that IL-1 induces the expression of
Figure 7. Interactions between the IL-1 and EGF signaling path-
ways. (A) The presence of EGF in the medium inhibits the induction of
K6 by IL-1. Keratinocytes grown in KGM do not respond to IL-1. A 16 h
incubation in the medium devoid of EGF is suf®cient to allow the
response; short incubations, 0 or 2 h are not. (B) Addition of EGF to KBM
inhibits the response to IL-1, whereas a change to KGM medium from
which EGF was omitted, allows the response. (C) IL-1 does not act
through the EGF pathway. Cotransfection of the construct expressing
EGFR augments the effect of EGF, but not of IL-1.
Figure 8. Insulin and interferon-g do not affect K6 expression.
Neither the basal nor the IL-1-induced levels of K6 expression are affected
by insulin or interferon-g. Interferon-g induces the expression of the IL-8
vector, and the effects of IL-1 and interferon-g are additive. Insulin does
not affect the IL-8 promoter.
Figure 9. Electrophoretic mobility shift assay demonstrating the
activation of NFkB and C/EBPb transcription factors by IL-1.
Radioactively labeled NFkB consensus element was used as the probe in
the left two lanes, the C/EBP containing sites from the K6 promoter in the
right four lanes. As the speci®c competitor we used an excess of unlabeled
probe in lane ``C'', whereas an excess of salmon sperm DNA served as the
nonspeci®c competitor in lane ``S.S.''. In lanes marked ``±'' we used protein
extracts from untreated keratinocytes, in all others extracts from IL-1-
treated ones were used. Note the induction of both NFkB and C/EBPb
binding activities by IL-1.
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the K6 promoter by activating transcription factor C/EBPb, which,
when activated, binds the cluster of C/EBP sites in the promoter of
the K6 keratin gene.
To initiate an analysis of the signal transduction pathway
responsive to IL-1 in keratinocytes we used a set of inhibitors of
cytoplasmic kinases. Speci®cally, bis-indolyl-maleimide, an inhi-
bitor of protein kinase C and phospholipase A, inhibited the IL-1
signaling (Fig 12). On the other hand dibutyril-cyclic adenosine
monophosphate and forskolin, activators of protein kinase A,
induced K6 promoter without signi®cantly affecting the IL-1
induction, whereas diacylglycerol suppressed the K6 promoter both
in the presence and in the absence of IL-1. Thus it seems that
protein kinase C and phospholipase A play a part in the signaling by
IL-1, whereas protein kinase A and the diacylglycerol-dependent
pathways do not.
DISCUSSION
In¯ammation in skin can be initiated by the release of IL-1 from
injured keratinocytes, and this initiation consists of production and
release of additional growth factors and cytokines that signal to the
surrounding tissues. Here we show that, in addition to initiating
additional downstream signals, IL-1 directly causes a speci®c
cytoskeletal change in keratinocytes, namely it induces the synthesis
of K6, a keratin protein marker of activated keratinocytes. The
Figure 10. Mapping the IL-1 responsive ele-
ment. (A) The sequence of the K6 promoter.
The consensus NFkB, AP1, and C/EBP elements
are over-lined, as is the TATA box. The initiating
methionine codon is underlined; the transcription
start is at +1. The endpoints of the deletions are
marked with triangles, the ``D'' series, the end-
points of the insertions into TK-CAT with arrows,
the ``E'' series. (B) Responses of the deletion con-
structs to IL-1 and EGF. The dashed line marks
the control levels of promoter activity in cultures
left untreated with IL-1 and EGF. Note that
D172 responds only partially to IL-1, whereas
D138 does not respond at all. Both are fully re-
sponsive to EGF.
Figure 11. The C/EBP sites impart respon-
siveness to IL-1. (A) K6 promoter DNA seg-
ments containing the C/EBP sites can confer
responsiveness to a heterologous, TK promoter.
The responsiveness to EGF has not been conferred
with these segments. (B) The C/EBP elements
bind the puri®ed C/EBPb in vitro. Gel shift assays
were performed using as the probe the K6 pro-
moter DNA sequence present in the ES construct
(see Fig 9), with puri®ed, bacterially expressed C/
EBPb. ``NS'' and ``Top'' represent nonspeci®c
bands and the top of the gel, whereas the speci®c
band is marked with ``C/EBPb''. (C) Overexpres-
sing C/EBPb greatly augments the activity of the
K6 promoter, both in the presence and in the ab-
sence of IL-1. In contrast, overexpressing CHOP
inhibits both the effects of IL-1 and of cotrans-
fected C/EBPb.
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expression of K6 keratin in the interfollicular epidermis is associated
with keratinocyte activation and hyperproliferation. The speci®c
role of K6 in these processes is not yet known, but it may be to
enhance either keratinocyte motility, or their hyperproliferation,
both of which are essential for wound healing (Takahashi et al,
1995). If so, IL-1 is signaling not only to the surrounding tissues
that an injury has occurred, but also to the keratinocytes to
commence the wound healing responses by, inter alia, inducing K6
expression.
The mechanism of K6 induction by IL-1 involves C/EBPb, a
protein implicated in IL-1 effects on transcription (Brasier et al,
1990). The same transcription factor plays a part in keratinocyte
differentiation (Maytin and Habener, 1998; Oh and Smart, 1998).
It is possible that the exclusively suprabasal expression of K6 in
hyperproliferative epidermis is due to the suprabasal presence of C/
EBPb. In addition, the receptor for IL-1 is also present exclusively
in the suprabasal cells (Groves et al, 1994, 1995). These ®ndings
correlate very well with our observation that only con¯uent
cultures of keratinocytes respond to IL-1, cultures comparable
more with differentiating, suprabasal cells than with proliferating,
basal ones.
It is curious that incubation of keratinocytes in EGF containing
medium inhibits the IL-1 induction of K6, whereas the
simultaneous addition of EGF and IL-1 acts synergistically. An
explanation for this may relate to the timing of the release of the IL-
1 and EGF signals during wound healing. IL-1 is present in the
epidermis before the injury. When released it induces the
expression, inter alia, of transforming growth factor-a and other
EGF analogs that activate the EGF signaling pathway. In the initial
activation, the IL-1 and EGF pathways synergize for a more rapid
or potent response. In later stages the continuous activation of the
EGF pathway attenuates the effects of IL-1. Thus, the IL-1
signaling can be thought of as inducing the in¯ammatory response,
whereas the EGF pathway can be thought of as maintaining it. The
fact that both the IL-1 and the EGF pathway induce expression of
K6 keratin means that K6 is necessary in both phases of the
in¯ammatory response.
The tissue-speci®c expression of K6 in the outer root sheath of
the hair follicle and in the nail bed has been studied in transgenic
animals (Navarro et al, 1995; Ramirez et al, 1995; Takahashi and
Coulombe, 1997). In these sites there is no in¯ammation and
extracellular IL-1 has not been detected. It is, therefore, not clear
whether the tissue-speci®c regulation and the extracellular signal
responsive regulation are autonomous, overlapping, or the same.
The status of relevant transcription factors, especially C/EBPb, in
the outer root sheath and nail bed is unknown, and it is possible
that in these tissues other transcription factors induce the expression
of K6. Alternatively, in these tissues C/EBPb may be activated
even in the absence of IL-1 signals.
In conclusion, we have shown that IL-1 directly causes
cytoskeletal changes in epidermal keratinocytes by inducing K6
expression and characterized the molecular mechanism of this
induction. These results de®ne a new function for proin¯ammatory
cytokines and a new regulatory in¯uence on keratin gene
expression.
We want to thank J. Vilcek, D. Ron, J. Schlessinger, and S. Chen-Kiang for gifts
of plasmids and E. K. Thomas and the Immunex Corp. for the gifts of chemicals.
We also thank M. Tomic-Canic for continuous interest and advice. The work was
supported by grants AR30682, AR40522, AR41850, AR39176, and
DK16636 from the National Institutes of Health.
REFERENCES
Akira S, Isshiki H, Sugita T, et al: A nuclear factor for IL-6 expression (NF-IL6) is a
member of a C/EBP family. EMBO J 9:1897±1906, 1991
Barker JN, Mitra RS, Grif®ths CE, Dixit VM, Nickoloff BJ: Keratinocytes as
initiators of in¯ammation. Lancet 337:211±214, 1991
Bernerd F, Magnaldo T, Freedberg IM, Blumenberg M: Expression of the
carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins.
Gene Expression 3:187±199, 1993
Bhora FY, Dunkin BJ, Batzri S, Aly HM, Bass BL, Sidawy AN, Harmon JW: Effect
of growth factors on cell proliferation and epithelialization in human skin. J
Surg Res 59:236±244, 1995
Bird T, Saklatvala J: IL-1 and TNF transmodulate epidermal growth factor receptors
by a protein kinase C-independent mechanism. J Immunol 142:126±133, 1989
Bowden PE, Haley JL, Kansky A, Rothnagel JA, Jones DO, Turner RJ: Mutation of
a type II keratin gene (K6a) in pachyonychia congenita. Nature Genet
10:363±365, 1995
Brasier A, Ron D, Tate J, Habener J: A family of constitutive C/EBP-like DNA
binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-
activation of the angiotensinogen gene acute-phase response element. EMBO J
9:3933±3944, 1990
Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: TRAF6 is a signal transducer
for interleukin-1. Nature 383:443±446, 1996
Dickinson AM, Sviland L, Hamilton PJ, et al: Cytokine involvement in predicting
clinical graft-versus-host disease in allogeneic bone marrow transplant
recipients. Bone Marrow Transplant 13:65±70, 1994
Dinarello CA, Wolff SM: The role of interleukin-1 in disease. N Engl J Med
328:106±113, 1993
Groves RW, Sherman L, Mizutani H, Dower SK, Kupper TS: Detection of
interleukin-1 receptors in human epidermis. Induction of the type II receptor
after organ culture and in psoriasis. Am J Pathol 145:1048±1056, 1994
Groves RW, Mizutani H, Kieffer JD, Kupper TS: In¯ammatory skin disease in
transgenic mice that express high levels of interleukin 1 alpha in basal
epidermis. Proc Natl Acad Sci USA 92:11874±11878, 1995
Groves RW, Rauschmayr T, Nakamura K, Sarkar S, Williams IR, Kupper TS:
In¯ammatory and hyperproliferative skin disease in mice that express elevated
levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that
IL-1-inducible secondary cytokines produced by keratinocytes in vivo can
cause skin disease. J Clin Invest 98:336±344, 1996
Hsu W, Chen-Kiang S: Convergent regulation of NF-IL6 and Oct-1 synthesis by
interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. Mol Cell
Biol 13:2515±2523, 1993
Jiang CK, Connolly D, Blumenberg M: Comparison of methods for transfection of
human epidermal keratinocytes. J Invest Dermatol 97:969±973, 1991
Jiang CK, Magnaldo T, Ohtsuki M, Freedberg IM, Bernerd F, Blumenberg M:
Epidermal growth factor and transforming growth factor alpha speci®cally
induce the activation- and hyperproliferation-associated keratins 6 and 16. Proc
Natl Acad Sci USA 90:6786±6790, 1993
Jiang CK, Flanagan S, Ohtsuki M, Shuai K, Freedberg IM, Blumenberg M: Disease-
activated transcription factor: allergic reactions in human skin cause nuclear
transcription of STAT-91 and induce synthesis of keratin K17. Mol Cell Biol
14:4759±4769, 1994
Klampfer L, Lee TH, Hsu W, Vilcek J, Chen-Kiang S: NF-IL6 and AP-1
cooperatively modulate the activation of the TSG-6 gene by tumor necrosis
factor alpha and interleukin-1. Mol Cell Biol 14:6561±6569, 1994
Komine M, Watabe Y, Kikuchi K, Nagawa H, Ishibashi Y: Interleukin 8 production
by cultured psoriatic keratinocytes. Jpn J Dermatol 103:1831±1835, 1993
Komine M, Freedberg IM, Blumenberg M: Interleukin-1 alpha is released during
transfection of keratinocytes. J Invest Dermatol 103:580±582, 1994
Komine M, Freedberg IM, Blumenberg M: Regulation of epidermal expression of
keratin K17 in in¯ammatory skin diseases. J Invest Dermatol 107:569±575, 1996
Komine M, Rao LS, Kaneko T, Tomic-Canic M, Tamaki K, Freedberg IM,
Blumenberg M: In¯ammatory versus proliferative processes in epidermis.
Tumor necrosis factor alpha induces K6b keratin synthesis through a
transcriptional complex containing NFkappa B and C/EBPbeta. J Biol Chem
275:32077±32088, 2000
Figure 12. The effects of signal transduction inhibitors. Bisindolyl-
maleimide (bis), an inhibitor of protein kinase C (PKC), diacyl-glycerol,
and pla, an inhibitor on phospholipase A, inhibited the induction by IL-1,
whereas dibutyril-cyclic adenosine monophosphate and Forskolin, activa-
tors of protein kinase A (PKA) activated the K6 promoter and enhanced the
effects of IL-1.
VOL. 116, NO. 2 FEBRUARY 2001 IL-1 REGULATES K6 KERATIN 337
Kupper TS. Role of epidermal cytokines. In Oppenheim JJ, Shevach EM (eds).
Immunophysiology The Role of Cells and Cytokines in Immunity and In¯ammation.
London: Oxford University Press, 1990, pp 285±305
Kupper TS, Groves RW: The interleukin-1 axis and cutaneous in¯ammation. J Invest
Dermatol 105:62S±66S, 1995
Lee JC, Laydon JT, McDonnell PC, et al: A protein kinase involved in the regulation
of in¯ammatory cytokine biosynthesis. Nature 372:739±746, 1994
Lu B, Rothnagel JA, Longley MA, Tsai SY, Roop DR: Differentiation-speci®c
expression of human keratin 1 is mediated by a composite AP-1/steroid
hormone element. J Biol Chem 269: 7443±7449, 1994
Ma S, Rao L, Freedberg IM, Blumenberg M: Transcriptional control of K5, K6,
K14, and K17 keratin genes by AP-1 and NF-kappaB family members. Gene
Expression 6:361±370, 1997
Magnaldo T, Bernerd F, Freedberg IM, Ohtsuki M, Blumenberg M: Transcriptional
regulators of expression of K#16, the disease-associated keratin. DNA Cell Biol
12:911±923, 1993
Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira
S: Transcription factors NF-IL6 and NF-kappa B synergistically activate
transcription of the in¯ammatory cytokines, interleukin 6 and interleukin 8.
Proc Natl Acad Sci USA 90:10193±10197, 1993
Maytin EV, Habener JF: Transcription factors C/EBP alpha, C/EBP beta, and
CHOP (Gadd153) expressed during the differentiation program of
keratinocytes in vitro and in vivo. J Invest Dermatol 110:238±246, 1998
Mizutani H, Black R, Kupper TS: Human keratinocytes produce but do not process
pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and
processing in monocytes and keratinocytes. J Clin Invest 87:1066±1071, 1991
Mutasim DF, Vaughan A, Supapannachart N, Farooqui J: Skin explant culture: a
reliable method for detecting pemphigoid antibodies in pemphigoid sera that
are negative by standard immuno¯uorescence and immunoblotting. J Invest
Dermatol 101:624±627, 1993
Navarro JM, Casatorres J, Jorcano JL: Elements controlling the expression and
induction of the skin hyperproliferation-associated keratin K6. J Biol Chem
270:21362±21367, 1995
Novak TJ, Chen D, Rothenberg EV: Interleukin-1 synergy with phosphoinositide
pathway agonists for induction of interleukin-2 gene expression: molecular
basis of costimulation. Mol Cell Biol 10:6325±6334, 1990
Oh HS, Smart RC: Expression of CCAAT/enhancer binding proteins (C/EBP) is
associated with squamous differentiation in epidermis and isolated primary
keratinocytes and is altered in skin neoplasms. J Invest Dermatol 110:939±945,
1998
Ollier S: Cutaneous responsesÐa window on in¯ammatory processes. Clin Exp
Allergy 22:3±6, 1992
Ramirez A, Vidal M, Bravo A, Larcher F, Jorcano JL: A 5¢-upstream region of a
bovine keratin 6 gene confers tissue-speci®c expression and hyperproliferation-
related induction in transgenic mice. Proc Natl Acad Sci USA 92:4783±4787,
1995
Randolph RK, Simon M: Characterization of retinol metabolism in cultured human
epidermal keratinocytes. J Biol Chem 268:9198±9205, 1994
Ron D, Habener JF: CHOP, a novel developmentally regulated nuclear protein that
dimerizes with transcription factors C/EBP and LAP and functions as a
dominant-negative inhibitor of gene transcription. Genes Dev 6:439±453, 1992
Schweizer J. Murine epidermal keratins. In Darmon M, Blumenberg M (eds).
Molecular Biology of the Skin: the Keratinocyte. New York: Academic Press, Inc.,
1993, pp 33±72
Sells SF, Muthukumar S, Sukhatme VP, Crist SA, Rangnekar VM: The zinc ®nger
transcription factor EGR-1 impedes interleukin-1-inducible tumor growth
arrest. Mol Cell Biol 15:682±692, 1995
Sica A, Van Matsushima K, Damme J, et al: IL-1 transcriptionally activates the
neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology
69:548±553, 1990
Simon M, Green H: Participation of membrane-associated proteins in the formation
of the cross-linked envelope of the keratinocyte. Cell 36:827±834, 1984
Sims JE, Gayle MA, Slack JL, et al: Interleukin 1 signaling occurs exclusively via the
type I receptor. Proc Natl Acad Sci USA 90:6155±6159, 1993
Stein B, Baldwin A: Distinct mechanisms for regulation of the interleukin-8 gene
involve synergism and cooperativity between C/EBP and NF-kappa B. Mol
Cell Biol 13:7191±7198, 1993
Stellmach V, Leask A, Fuchs E: Retinoid-mediated transcriptional regulation of
keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl
Acad Sci USA 88: 4582±4586, 1991
Stoll S, Garner W, Elder J: Heparin-binding ligands mediate autocrine epidermal
growth factor receptor activation in skin organ culture. J Clin Invest
100:1271±1281, 1997
Takahashi K, Paladini RD, Coulombe PA: Cloning and characterization of multiple
human genes and cDNA encoding highly related type II keratin 6 isoforms. J
Biol Chem 270:18581±18592, 1995
Takahashi K, Coulombe PA: De®ning a region of the human keratin 6a gene that
confers inducible expression in strati®ed epithelia of transgenic mice. J Biol
Chem 272:11979±11985, 1997
Tomic-Canic M, Komine M, Freedberg IM, Blumenberg M: Epidermal signal
transduction and transcription factor activation in activated keratinocytes. J
Dermatol Sci 17:167±181, 1998
338 KOMINE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
